US OptionsDetailed Quotes
TGTX250502P44000
- 0.16
- -0.60-78.95%
15min DelayClose May 1 16:00 ET
0.17High0.16Low
0.17Open0.76Pre Close11 Volume77 Open Interest44.00Strike Price177.00Turnover87.79%IV3.37%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type-0.1834Delta0.1686Gamma283.56Leverage Ratio-0.3673Theta-0.0001Rho-52.00Eff Leverage0.0048Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet